Skip to main content
Download PDF

Correction to: Clinical features and treatment efficacy for IgG4-related thyroiditis

Orphanet Journal of Rare Diseases volume 16, Article number: 459 (2021) Cite this article

The Original Article was published on 21 July 2021

Correction to: Orphanet J Rare Dis (2021) 16:324 https://doi.org/10.1186/s13023-021-01942-x

It was highlighted that in the original article [1] the Funding section was incomplete. This Correction article shows the complete Funding section. The original article has been updated.

Reference

  1. Han, et al. Clinical features and treatment efcacy for IgG4-related thyroiditis. Orphanet J Rare Dis. 2021;16:324. https://doi.org/10.1186/s13023-021-01942-x.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by The National Key Research and Development Program of China [2016YFC0901500], CAMS Innovation Fund for Medical Sciences (CIFMS) [2017-I2M-3-001], The capital health research and development special (No. 2020-2-4017),Beijing Municipal Science and Technology Commission (No. Z201100005520023) and Clinical and translational medical research fund of Chinese Academy of Medical Sciences to Xuejun Zeng (No. 2019XK320013), CAMS Innovation Fund for Medical Science (CIFMS) to Xuejun Zeng (No. 2020-I2M-2-009).

Author information

Authors and Affiliations

  1. Department of General Practice, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, People’s Republic of China

    Xinxin Han & Xuejun Zeng

  2. Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Education and National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), No.1 Shuai Fu Yuan, Dong Cheng District, Beijing, 100730, People’s Republic of China

    Panpan Zhang, Jieqiong Li, Zheng Liu, Hui Lu, Xuan Luo, Wen Zhang & Xiaofeng Zeng

  3. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, People’s Republic of China

    Boju Pan

  4. Department of Endocrine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, State Key Laboratory of Complex Severe and Rare Diseases, Beijing, People’s Republic of China

    Xiaolan Lian

Authors
  1. Xinxin Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Panpan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jieqiong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zheng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hui Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xuan Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Boju Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiaolan Lian
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xuejun Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiaofeng Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xuejun Zeng or Wen Zhang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, X., Zhang, P., Li, J. et al. Correction to: Clinical features and treatment efficacy for IgG4-related thyroiditis. Orphanet J Rare Dis 16, 459 (2021). https://doi.org/10.1186/s13023-021-02071-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13023-021-02071-1

Orphanet Journal of Rare Diseases

ISSN: 1750-1172